NSRGY Stock Recent News
NSRGY LATEST HEADLINES
A new line of frozen foods will cater to users of weight loss drugs like Ozempic and Wegovy. Nestlé's Vital Pursuit brand will include sandwiches and bowls.
Nestle is to launch a new range of cheap frozen pizzas and pasta in the US to tap into the burgeoning market for users of weight loss drugs such as Wegovy and Ozempic. The new products, which will sell for US$5, come with more protein, iron and calcium designed for the appetite-suppressing drugs, called GLP-1 agonists.
Nestle is to launch a new range of cheap frozen pizzas and pasta in the US to tap into the burgeoning market for users of weight loss drugs such as Wegovy and Ozempic. The new products, which will sell for US$5, come with more protein, iron and calcium designed for the appetite-suppressing drugs, called GLP-1 agonists.
Nestle's Vital Pursuit brand's initial lineup of 12 items will include frozen bowls with whole grains or protein pasta, sandwich melts and pizzas.
Nestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as Wegovy or Ozempic for weight loss.
Erez Israeli, CEO of Dr Reddy's Laboratories, discusses its joint venture with Nestle India.
Nestlé S.A (OTCPK:NSRGY) Q1 2024 Earnings Conference Call April 25, 2024 8:00 AM ET Company Participants Mark Schneider - Chief Executive Officer Anna Manz - Chief Financial Officer Luca Borlini - Head of Investor Relations Conference Call Participants Warren Ackerman - Barclays Jon Cox - Kepler Guillaume Delmas - UBS Celine Pannuti - JPMorgan Jeremy Fialko - HSBC Pascal Boll - Stifel Bruno Monteyne - Bernstein Sarah Simon - Morgan Stanley Jeff Stent - Exane Tom Sykes - Deutsche Bank David Hayes - Jefferies Luca Borlini Good morning to everyone. This is Luca Borlini, Head of Nestlé Investor Relations.
Nestlé S.A. (OTC:NSRGF, VTX:NESN) shares sank to around a four-year low after the Nespresso and Kitkat maker's underlying growth was down in the first three months of the year due to further softening of US consumer demand.
While price rises are starting to slow for companies like Nestle and Unilever after months of heading higher, the battle to win back consumers is far from over.
Nestle's first-quarter organic sales missed forecasts as consumer demand remained weak, particularly in North America, while supply-chain disruptions continued to hold back volumes.